Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: Frequency and risk factors

Ophthalmic Epidemiology

Volumn 18, Issue 6, 2011, Pages 269-274

  Sarikabadayi, Yusuf Unal ^a   Aydemir, Ozge ^a   Ozen, Zuhal Tunay ^b   Aydemir, Cumhur ^a   Tok, Levent ^b   Oguz, Serife Suna ^a   Erdeve, Omer ^a   Uras, Nurdan ^a   Dilmen, Ugur ^a  

^a Neonatal Intensive Care Unit   (Turkey)

^b Zekai Tahir Burak Maternity Hospital   (Turkey)

Author keywords

Prematurity; Retinopathy; Risk factors; Screening

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SCREENING; PATENT DUCTUS ARTERIOSUS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; RISK FACTOR; TREATMENT DURATION; TURKEY (REPUBLIC);

BIRTH WEIGHT; COHORT STUDIES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; MALE; PRACTICE GUIDELINES AS TOPIC; RETINOPATHY OF PREMATURITY; RISK FACTORS; TURKEY;

EID: 80755159043     PISSN: 09286586     EISSN: 17445086     Source Type: Journal    
DOI: 10.3109/09286586.2011.615449     Document Type: Article

References (36)

1. Terry TL. Extreme prematurity and fbroblastic overgrowth of persistent vascular sheath behind each crystalline lens. Am J Ophthalmol 1942;24:203-204.
2. Fortes Filho JB, Eckert GU, Procianoy L, et al. Incidence and risk factors for retinopathy of prematurity in very low and in extremely low birth weight infants in a unit-based approach in southern Brazil. Eye (Lond) 2009;23:25-30.
3. Binkhathlan AA, Almahmoud LA, Saleh MJ, et al. Retinopathy of prematurity in Saudi Arabia: incidence, risk factors, and the applicability of current screening criteria. Br J Ophthalmol 2008;92:167-169. (Pubitemid 351224087)
4. Chen Y, Li XX, Yin H, Gilbert C, et al. Beijing ROP Survey Group. Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China. Br J Ophthalmol 2008;92:326-330. (Pubitemid 351363522)
5. Wright KW, Sami D, Thompson L, et al. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc 2006;104:78-84.
6. Nodgaard H, Andreasen H, Hansen H, et al. Risk factors associated with retinopathy of prematurity (ROP) in northern Jutland, Denmark 1990-1993. Acta Ophthalmol Scand 1996;74:306-310. (Pubitemid 26229735)
7. Karkhaneh R, Mousavi SZ, Riazi-Esfahani M, et al. Incidence and risk factors of retinopathy of prematurity in a tertiary eye hospital in Tehran. Br J Ophthalmol 2008;92:1446-1449.
8. Shah VA, Yeo CL, Ling YL, et al. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 2005;34:169-178. (Pubitemid 40545454)
9. Lang DM, Blackledge J, Arnold RW. Is Pacifc race a retin-opathy of prematurity risk factor? Arch Pediatr Adolesc Med 2005;159:771-773. (Pubitemid 41126842)
10. Phan MH, Nguyen PN, Reynolds JD. Incidence and severity of retinopathy of prematurity in Vietnam, a developing middle-income country. J Pediatr Ophthalmol Strabismus 2003;40:208-212. (Pubitemid 36890544)
11. Gilbert C, Fielder A, Gordillo L, et al. International NO-ROP Group. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics 2005;115:518-525.
12. International Committee for the Classifcation of Retinopathy of Prematurity. The International Classifcation of Retinopathy of Prematurity revisited. Arch Opthalmol 2005;123:991-999.
13. Early Treatment For Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopa-thy of prematurity: results of the early treatment for retin-opathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-1694.
14. King M. Retrolental fbroplasia. Arch Ophthalmol 1950;43:695-709.
15. Gilbert C, Rahi J, Eckstein M, et al. Retinopathy of prematurity in middle-income countries. Lancet 1997;350:12-14.
16. Chen Y, Xi L. Characteristics of severe retinopathy of prematurity patients in China: a repeat of the frst epidemic? Br J Ophthalmol 2006;90:268-271. (Pubitemid 43325452)
17. Mutlu FM, Altinsoy HI, Mumcuoglu T, et al. Screening for retinopathy of prematurity in a tertiary care newborn unit in Turkey: frequency, outcomes, and risk factor analysis. J Pediatr Ophthalmol Strabismus 2008;45:291-298.
18. Akman I, Demirel U, Yenice O, et al. Screening criteria for retinopathy of prematurity in developing countries. Eur J Ophthalmol 2010;20:931-937.
19. Erdeve O, Atasay B, Arsan S, et al. Restricted universal guidelines for ROP screening: a possible misguidance for middle income countries. Turk J Med Sci 2010;40:791-796.
20. Basmak H, Niyaz L, Sahin A, et al. Retinopathy of prematurity: screening guidelines need to be reevaluated for developing countries. Eur J Ophthalmol 2010;20:752-755.
21. Wilkinson AR, Haines L, Head K, et al. UK retinopathy of prematurity guideline. Early Hum Dev 2008;84:71-74. (Pubitemid 351233028)
22. Section on Ophthalmology, American Academy of Ophthalmology, the American Academy of Pediatrics and the American Association of Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006;117:572-576.
23. Erratum in: Pediatrics 2006;118:1324.
24. Darlow BA, Hutchinson JL, Henderson-Smart DJ, et al. Australian and New Zealand Neonatal Network. Prenatal risk factors for severe retinopathy of prematurity among very preterm infants of the Australian and New Zealand Neonatal Network. Pediatrics 2005;115:990-996.
25. Cooke RW, Clark D, Hickey-Dwyer M, et al. The apparent role of blood transfusions in the development of retinopathy of prematurity. Eur J Pediatr 1993;152:833-836. (Pubitemid 23280678)
26. Hirano K, Morinobu T, Kim H, et al. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch Dis Child Fetal Neonatal Ed 2001;84:188-193.
27. Hesse L, Eberl W, Schlaud M, et al. Blood transfusion. Iron load and retinopathy of prematurity. Eur J Pediatr 1997;156:465-470. (Pubitemid 27261513)
28. Aggarwal R, Deorari AK, Azad RV, et al. Changing profle of retinopathy of prematurity. J Trop Pediatr 2002;48: 239-242.
29. Liu PM, Fang PC, Huang CB, et al. Risk factors of retinopa-thy of prematurity in premature infants weighing less than 1600 g. Am J Perinatol 2005;22:115-120.
30. Dammann O, Brinkhaus MJ, Bartels DB, et al. Immaturity, perinatal infammation, and retinopathy of prematurity: a multi-hit hypothesis. Early Hum Dev 2009;85:325-329.
31. Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol 2006;26:46-50.
32. Chow LC, Wright KW, Sola A. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics 2003;111:339-345. (Pubitemid 36177154)
33. Chen ML, Guo L, Smith LE, et al. High or low oxygen saturation and severe retinopathy of prematurity: a meta-analysis. Pediatrics 2010;125:1483-1492.
34. McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated fuc-tuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis 2004;10:512-520. (Pubitemid 41358245)
35. John E, Todd DA. Patent ductus arteriosus and retinopathy of prematurity in infants below 27 weeks gestation. Aust Paediatr J 1988;24:171-173.
36. Goldman RD, Spierer A, Zhurkovsky A, et al. Retinopathy of prematurity in very low birth weight infants and the potential protective role of indomethacin. Ophthalmic Surg Lasers Imaging 2010;41:41-47.